The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Diabetes and atherosclerosis: An epidemiologic view
Abstract
Diabetes is associated with changes in plasma lipids and lipoproteins into atherogenic direction. In IDDM these changes are small or absent if good metabolic control can be maintained. Diabetic nephropathy is, however, associated with the appearance of dyslipoproteinemia. In NIDDM plasma total and VLDL triglyceride levels are elevated, and HDL-cholesterol level is decreased, and this pattern of dyslipoproteinemia does not always respond to improved control of hyperglycemia. Abnormalities of lipoprotein metabolism, not reflected in conventional plasma lipid and lipoprotein level measurements, and glucosylation of lipoproteins and resulting alterations in lipoprotein catabolism may be of importance in the enhanced atherogenesis in diabetes. Both IDDM and NIDDM are associated with an increased frequency of hypertension, but the underlying mechanisms appear to be different. In IDDM hypertension is usually associated with the development of diabetic nephropathy and thus with a long duration of the disease. In NIDDM hypertension is often present already at the time of diagnosis, and also in IGT, the precursor stage of NIDDM, the prevalence of hypertension is already increased. Obesity explains only in part the high prevalence of hypertension in patients with NIDDM. Diabetes is known to be associated with multiple abnormalities in hemostatic factors and, although these abnormalities may contribute importantly to the increased risk of ASVD in diabetic patients, information about their real role is scanty and conflicting. The impact of general major risk factors for ASVD, elevated plasma cholesterol, elevated blood pressure, and smoking, on the risk of ASVD appears to be similar in diabetics and nondiabetics. Only a relatively small proportion of the excessive occurrence of ASVD in diabetics can, however, be explained by the effects of diabetes on the levels of general risk factors for ASVD. This proportion mediated through the effects of diabetes on risk factors is larger in female diabetics than in male diabetics. The major proportion of the excess of ASVD in diabetics remains, however, unexplained and must be due to effects of diabetes itself through mechanisms that are incompletely understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Cardiovascular Survey Methods.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,052
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
Garcia, M. J., McNamara, P. M., Gordon, T., & Kannell, W. B. (1974) · Diabetes · doi:10.2337/diab.23.2.105 · Cited by 1,608
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Diabetes and cardiovascular risk factors: the Framingham study
Kannel, W. B., & McGee, D. L. (1979) · Circulation · doi:10.1161/01.cir.59.1.8 · Cited by 1,317
Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
Kannel, W. B., & McGee, D. L. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.120 · Cited by 1,203
World Health Organization Technical Report Series
(1972) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/55.3.666 · Cited by 917
CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study
Fuller, J., Shipley, M., Rose, G., Jarrett, R. J., & Keen, H. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92651-3 · Cited by 783
Cited by
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Self-citationStamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Self-citationPrepared by: British Cardiac Society, B. H. S. (2005) · Heart · doi:10.1136/hrt.2005.079988 · Cited by 1,216
Second Joint Task Force of European (1998) · European Heart Journal · doi:10.1053/euhj.1998.1243 · Cited by 1,131
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,003
Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moyé, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.23.2513 · Cited by 986
Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873
“The central importance of hypertension control in the early phases of diabetes is a consistent finding in most epidemiological studies [2].”
ResultTreatment of obesity: need to focus on high risk abdominally obese patients
Després, J.-P., Lemieux, I., & Prud'homme, D. (2001) · BMJ · doi:10.1136/bmj.322.7288.716 · Cited by 826
Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815
Peripheral Arterial Disease in Diabetic and Nondiabetic Patients
Jude, E. B., Oyibo, S. O., Chalmers, N., & Boulton, A. J. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1433 · Cited by 810
Criqui, M. H., Matsushita, K., Aboyans, V., Hess, C. N., Hicks, C. W., Kwan, T. W., McDermott, M. M., Misra, S., Ujueta, F., & on behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, T. A. V. B. C. O. C. R. A. I. C. O. L. A. C. H. C. O. P. V. D. A. S. C. (2021) · Circulation · doi:10.1161/cir.0000000000001005 · Cited by 809
Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742
de Jager, J., Kooy, A., Lehert, P., Wulffele, M. G., van der Kolk, J., Bets, D., Verburg, J., Donker, A. J. M., & Stehouwer, C. D. A. (2010) · BMJ · doi:10.1136/bmj.c2181 · Cited by 702
Jeppesen, J. Ø., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 676
Impact of Diabetes on Mortality After the First Myocardial Infarction
Miettinen, H., Lehto, S., Salomaa, V., Mähönen, M., Niemelä, M., Haffner, S. M., Pyörälä, K., Tuomilehto, J., & The FINMONICA Myocardial Infarction Register Study Group (1998) · Diabetes Care · doi:10.2337/diacare.21.1.69 · Cited by 665
“I t is well established that the incidence of and mortality from coronary heart disease (CHD) are higher in diabetic patients than in nondiabetic patients (1).”
BackgroundSelf-citationHanefeld, M. (2004) · European Heart Journal · doi:10.1016/s0195-668x(03)00468-8 · Cited by 641
Microalbuminuria as predictor of increased mortality in elderly people.
Damsgaard, E. M., Frøland, A., Jørgensen, O. D., & Mogensen, C. E. (1990) · BMJ · doi:10.1136/bmj.300.6720.297 · Cited by 609
Diabetes mellitus and hypertension.
Epstein, M., & Sowers, J. R. (1992) · Hypertension · doi:10.1161/01.hyp.19.5.403 · Cited by 600
Lehto, S., Niskanen, L., Suhonen, M., Rönnemaa, T., & Laakso, M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.978 · Cited by 594
Self-citationBailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593
Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implications
Rocha‐Singh, K. J., Zeller, T., & Jaff, M. R. (2014) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25387 · Cited by 587
Peripheral Arterial Disease in Patients With Diabetes
Marso, S. P., & Hiatt, W. R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.065 · Cited by 575
Grundy, S. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.14.1568 · Cited by 551
Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus
Panzram, G. (1987) · Diabetologia · doi:10.1007/bf00274216 · Cited by 541
Chen, Z., Peto, R., Collins, R., MacMahon, S., Lu, J., & Li, W. (1991) · BMJ · doi:10.1136/bmj.303.6797.276 · Cited by 537
Pre-Diabetes and the Risk for Cardiovascular Disease
Ford, E. S., Zhao, G., & Li, C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.060 · Cited by 480
Garin, M. C., James, R. W., Dussoix, P., Blanché, H., Passa, P., Froguel, P., & Ruiz, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119134 · Cited by 476
Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status: The Hoorn Study
Henry, R. M. A., Kostense, P. J., Spijkerman, A. M. W., Dekker, J. M., Nijpels, G., Heine, R. J., Kamp, O., Westerhof, N., Bouter, L. M., & Stehouwer, C. D. A. (2003) · Circulation · doi:10.1161/01.cir.0000065222.34933.fc · Cited by 471
Diabetes Mellitus, Aortic Stiffness, and Cardiovascular Mortality in End-Stage Renal Disease
SHOJI, T., EMOTO, M., SHINOHARA, K., KAKIYA, R., TSUJIMOTO, Y., KISHIMOTO, H., ISHIMURA, E., TABATA, T., & NISHIZAWA, Y. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102117 · Cited by 450
Assmann, G., & Schulte, H. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90220-7 · Cited by 449
Haffner, S. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2661 · Cited by 441
Miettinen, H., Lehto, S., Saikku, P., Haffner, S. M., Ronnemaa, T., Pyorala, K., & Laakso, M. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014934 · Cited by 447
Self-citationJärvisalo, M. J., Raitakari, M., Toikka, J. O., Putto-Laurila, A., Rontu, R., Laine, S., Lehtimäki, T., Rönnemaa, T., Viikari, J., & Raitakari, O. T. (2004) · Circulation · doi:10.1161/01.cir.0000124725.46165.2c · Cited by 447
T HE H EALTH B ENEFITS OF W INE
German, J. B., & Walzem, R. L. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.561 · Cited by 429
Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. M., White, H. D., et al. (2001) · Circulation · doi:10.1161/hc4801.100029 · Cited by 428
Schram, M. T., Henry, R. M. A., van Dijk, R. A. J. M., Kostense, P. J., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., Westerhof, N., & Stehouwer, C. D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000111829.46090.92 · Cited by 428
George Lyman Duff Memorial Lecture. Atherogenesis in diabetes.
Bierman, E. L. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.647 · Cited by 413
Lehto, S., Niskanen, L., Rönnemaa, T., & Laakso, M. (1998) · Stroke · doi:10.1161/01.str.29.3.635 · Cited by 411
Self-citationNon-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes
Lu, W., Resnick, H. E., Jablonski, K. A., Jones, K. L., Jain, A. K., Howard, W. J., Robbins, D. C., & Howard, B. V. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.16 · Cited by 370
Sabaté, M., Jiménez-Quevedo, P., Angiolillo, D. J., Gómez-Hospital, J. A., Alfonso, F., Hernández-Antolín, R., Goicolea, J., Bañuelos, C., Escaned, J., Moreno, R., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.562421 · Cited by 368
Hariharan, R., Odjidja, E. N., Scott, D., Shivappa, N., Hébert, J. R., Hodge, A., & de Courten, B. (2022) · Obesity Reviews · doi:10.1111/obr.13349 · Cited by 361
Uusitupa, M. I. J., Niskanen, L. K., Siitonen, O., Voutilainen, E., & Py�r�l�, K. (1993) · Diabetologia · doi:10.1007/bf00401063 · Cited by 353
Self-citationPalmieri, V., Bella, J. N., Arnett, D. K., Liu, J. E., Oberman, A., Schuck, M.-Y., Kitzman, D. W., Hopkins, P. N., Morgan, D., Rao, D. C., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.102 · Cited by 339
Biology of Platelet-Derived Growth Factor and Its Involvement in Disease
Alvarez, R. H., Kantarjian, H. M., & Cortes, J. E. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1241 · Cited by 334
Pathophysiology of oxidative stress in diabetes mellitus
Lipinski, B. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00143-x · Cited by 324
PYORALA, K., DEBACKER, G., GRAHAM, I., POOLEWILSON, P., & WOOD, D. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90200-3 · Cited by 329
Carotid Artery Intima-Media Thickness in Children With Type 1 Diabetes
Järvisalo, M. J., Putto-Laurila, A., Jartti, L., Lehtimäki, T., Solakivi, T., Rönnemaa, T., & Raitakari, O. T. (2002) · Diabetes · doi:10.2337/diabetes.51.2.493 · Cited by 316
The Finnish Diabetes Prevention Study
Uusitupa, M., Louheranta, A., Lindström, J., Valle, T., Sundvall, J., Eriksson, J., & Tuomilehto, J. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500001070 · Cited by 306
Self-citationand the WHO Multinational Study Group, Fuller, J., Stevens, L., & Wang, S.-L. (2001) · Diabetologia · doi:10.1007/pl00002940 · Cited by 301
Beks, P. J., Mackaay, A. J. C., de Neeling, J. N. D., de Vries, H., Bouter, L. M., & Heine, R. J. (1995) · Diabetologia · doi:10.1007/bf02369357 · Cited by 299
Uusitupa, M. I., Niskanen, L. K., Siitonen, O., Voutilainen, E., & Pyörälä, K. (1990) · Circulation · doi:10.1161/01.cir.82.1.27 · Cited by 291
Self-citationDe Backer, G., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention and Rehabilitation · doi:10.1097/00149831-200312001-00001 · Cited by 274
Self-citationType II Diabetes Abrogates Sex Differences in Endothelial Function in Premenopausal Women
Steinberg, H. O., Paradisi, G., Cronin, J., Crowde, K., Hempfling, A., Hook, G., & Baron, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.17.2040 · Cited by 272
Diabetes-Induced Accelerated Atherosclerosis in Swine
Gerrity, R. G., Natarajan, R., Nadler, J. L., & Kimsey, T. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1654 · Cited by 270
Barter, P. J., Brandrup-Wognsen, G., Palmer, M. K., & Nicholls, S. J. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p002816 · Cited by 259
The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it?
Nathan, D. M., Meigs, J., & Singer, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90021-0 · Cited by 265
Stephens, J. W., Khanolkar, M. P., & Bain, S. C. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.006 · Cited by 262
Miettinen, H., Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1996) · Stroke · doi:10.1161/01.str.27.11.2033 · Cited by 257
Self-citationSmoking and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus
Al-Delaimy, W. K., Manson, J. E., Solomon, C. G., Kawachi, I., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.273 · Cited by 173
de Jager, J., Dekker, J. M., Kooy, A., Kostense, P. J., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000215951.36219.a4 · Cited by 163
Ye, X., Kong, W., Zafar, M. I., & Chen, L.-L. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0851-z · Cited by 138
Sobenin, I. A., Nedosugova, L. V., Filatova, L. V., Balabolkin, M. I., Gorchakova, T. V., & Orekhov, A. N. (2008) · Acta Diabetologica · doi:10.1007/s00592-007-0011-x · Cited by 119
“[3]. Among all risk factors of atherosclerosis, diabetes mellitus is thought to be one the most potent that greatly increases the risk of cardiovascular diseases of atherosclerotic origin [ 4 , 5]. Dietary therapy is generally considered to be the first step in the treatment of diabetic patients.”
Lipid modification in type 2 diabetes: the role of LDL and HDL
Vergès, B. (2009) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00739.x · Cited by 117
Uusitupa, M. I. J. (1996) · Annals of Medicine · doi:10.3109/07853899608999106 · Cited by 91
Self-citationVaccaro, O. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.4.636 · Cited by 69
Lecis, D., Prandi, F. R., Barone, L., Belli, M., Sergi, D., Longo, S., Muscoli, S., Romeo, F., Federici, M., Lerakis, S., et al. (2023) · Biomolecules · doi:10.3390/biom13121695 · Cited by 23
Kanaya, A. M., Grady, D., & Barrett-Connor, E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1737 · Cited by 1
Metadata
- Authors
- Pyörälä, K., Laakso, M., & Uusitupa, M.
- Venue
- Diabetes/Metabolism Reviews
- Publisher
- Wiley
- Published
- 1987-04
- Volume
- 3
- Issue
- 2
- Pages
- 463-524
- ISSN
- 0742-4221 (ISSN-L)
- 1099-0895
- OpenAlex
- W2100500261
- Cited by
- 919
- References
- 162
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.